Agenda (Central European Time)

Conference Program
Flip through our 2021 conference brochure and discover what’s new this year.
- Jump to:
- At a Glance
- Day 1
- Day 2
- Day 3
- Print-friendly Format
Day 1 - Tuesday, February 23, 2021
Day 2 - Wednesday, February 24, 2021
12:10 |
Remarks and Recap from the Co-Chairs |
12:15 |
AUDIENCE POLLINGEffectively Managing Global Pharmaceutical and Biotech Patent Litigation |
1:15 |
A Study in Carve Outs Post-GSK v. Teva: Contrasting the Approach in the U.S. and Europe |
2:15 |
1:1 Networking Break |
3:15 |
AUDIENCE POLLINGRegeneron v. Kymab and The Lack of Sufficiency: A Game of Cat and Mouse Crescendos |
4:15 |
Biologics and Biosimilars: Global Patent Litigation Strategies for Success |
5:30 |
Conference Adjourns to Day Three |
Day 3 - Thursday, February 25, 2021
12:10 |
Remarks and Recap from the Co-Chairs |
12:15 |
AUDIENCE POLLINGBREXIT and Supplementary Protection Certificates |
1:15 |
1:1 Networking Break |
2:15 |
Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across Europe |
3:15 |
Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations |
4:30 |
Conference Concludes |
Day 1 - Tuesday, February 23, 2021
12:00 |
Opening Remarks from the Co-ChairsDominic Adair Bert Oosting |
12:30 |
Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel CoronavirusKarin Hessler The novel coronavirus has instigated arguably the most important patent story of the year. The virus has introduced novel challenges for the pharmaceutical and biotech patent communities. This opening session will analyze the challenges pharmaceutical companies are currently facing as they look toward the next phases of the coronavirus response and recovery.
|
1:30 |
AUDIENCE POLLINGThe Evolution of Safe Harbours and Patent Exemptions in Europe and The United States: Understanding the Expanding Reformation to Patent InfringementAndrea Pucci Dr. Dean Thomas Brian D. Coggio
|
2:15 |
1:1 Networking Break |
3:00 |
Proportionality, Preliminary Injunctions & Damages: The Ability to Deny, Grant or Tailor Injunctive ReliefBeatriz Diaz de Ezcauriaza Professor Dr. Maximilian Haedicke Daan de Lange Thorsten Bausch
|
4:00 |
AUDIENCE POLLINGArrow Declarations and Cross-Border Measures for Relief: Evaluating the Expanding Reach of Their ApplicationBert Oosting Koen Bijvank Dr. Beatriz San Martin
|
5:30 |
Virtual Opposition Proceedings Before the EPO, the Appeal Court of the Hague and in the PTABHon. Jacqueline Wright Bonilla Dr. Corinna Sundermann Jonathan E. Singer
|
6:30 |
Conference Adjourns to Day Two |
Day 2 - Wednesday, February 24, 2021
12:10 |
Remarks and Recap from the Co-Chairs |
12:15 |
AUDIENCE POLLINGEffectively Managing Global Pharmaceutical and Biotech Patent LitigationErin M. Sommer, Ph.D. Benjamin May Guido Pontremoli, Ph.D.
|
1:15 |
A Study in Carve Outs Post-GSK v. Teva: Contrasting the Approach in the U.S. and EuropeWillem F.C. de Weerd Hans Sauer, Ph.D., J.D. Jennifer Antcliff
|
2:15 |
1:1 Networking Break |
3:15 |
AUDIENCE POLLINGRegeneron v. Kymab and The Lack of Sufficiency: A Game of Cat and Mouse CrescendosNicole Jadeja Dr Penny Gilbert
|
4:15 |
Biologics and Biosimilars: Global Patent Litigation Strategies for SuccessDavid E. Korn Shohta Ueno, PhD Roberto Ribeiro
|
5:30 |
Conference Adjourns to Day Three |
Day 3 - Thursday, February 25, 2021
12:10 |
Remarks and Recap from the Co-Chairs |
12:15 |
AUDIENCE POLLINGBREXIT and Supplementary Protection CertificatesLaura Reynolds Marie Manley
|
1:15 |
1:1 Networking Break |
2:15 |
Doctrine of Equivalents Applied: Analyzing the Effects of Recent Decisions on Litigation Strategies in the UK and Across EuropeSara Burghart Jules Fabre Dominic Adair Dr. Jochen Herr LL.M. Across the globe, the extent of protection afforded by a patent is generally defined by the claims “as read”, or, under the Doctrine of Equivalents. Proving infringement under the doctrine is based on legislation and/or jurisprudence. This session will consider the current status of the Doctrine of Equivalents in Europe, highlighting the laws as they currently exist in, Germany, France, the Netherlands and the United Kingdom.
|
3:15 |
Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic ConsiderationsRainer Becker
|
4:30 |
Conference Concludes |